Alterity Financial Group’s AbbVie ABBV Stock Holding History

Alterity Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$755K	Sell	4,871 -144	-3%	-$21K	1.08%	28
2023 Q3	$748K	Buy	5,015 +230	+5%	+$33.8K	1.18%	26
2023 Q2	$645K	Sell	4,785 -461	-9%	-$67.6K	0.93%	29
2023 Q1	$836K	Sell	5,246 -50	-0.9%	-$7.64K	1.22%	24
2022 Q4	$856K	Buy	5,296 +190	+4%	+$29.1K	1.39%	22
2022 Q3	$685K	Buy	5,106 +216	+4%	+$31K	1.11%	26
2022 Q2	$749K	Buy	+4,890	New	+$747K	1.11%	24
2021 Q4	$616K	Buy	+4,549	New	+$537K	0.66%	43
2021 Q1	$861K	Buy	+5,310	New	+$568K	1.04%	27

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alterity Financial Group's ABBV Position: Q4 2023 in Review

Alterity Financial Group reduced its AbbVie (ABBV) stake by 2.9% in Q4 2023, selling an estimated $21K and leaving 4,871 shares worth $755K. The position accounts for 1.08% of the portfolio, ranked #28.

Alterity Financial Group first reported a position in ABBV in Q1 2021 and has held it in 9 quarters since. The position peaked at $861K in Q1 2021. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

Alterity Financial Group held 4,871 shares of AbbVie worth $755K as of Q4 2023.
Alterity Financial Group sold 144 AbbVie shares in Q4 2023, an estimated $21K.
AbbVie made up 1.08% of Alterity Financial Group's portfolio in Q4 2023, its #28 holding.
Alterity Financial Group first reported a position in AbbVie in Q1 2021 and has held it in 9 quarters since.
Alterity Financial Group's AbbVie position peaked at $861K in Q1 2021.
3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Alterity Financial Group's 13F filing for Q4 2023, filed 18 Jan 2024.